ducovest

3081:HK:HK-Value Gold ETF (HKD)

ETF | Others |

Last Closing

USD 78.92

Change

+0.14 (+0.18)%

Market Cap

USD 2.72B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: HKD

Country : Hong Kong

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

N/A

 USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

 USD 30.97B
2828:HK Hang Seng China Enterprises In..

N/A

 USD 30.56B
2801:HK iShares Core MSCI China ETF

N/A

 USD 22.44B
2823:HK iShares FTSE A50 China

N/A

 USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

N/A

 USD 13.48B
9067:HK iShares Hang Seng TECH ETF

N/A

 USD 9.22B
3067:HK iShares Hang Seng TECH ETF

N/A

 USD 9.22B
82822:HK CSOP FTSE China A50

N/A

 USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

N/A

 USD 3.03B

ETFs Containing 3081:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.74% 88% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.74% 88% B+ 83% B
Trailing 12 Months  
Capital Gain 42.15% 86% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.15% 86% B+ 82% B
Trailing 5 Years  
Capital Gain 89.03% 86% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.03% 84% B 83% B
Average Annual (5 Year Horizon)  
Capital Gain 10.56% 79% B- 71% C-
Dividend Return 10.56% 78% C+ 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.41% 72% C 88% B+
Risk Adjusted Return 73.28% 92% A 95% A
Market Capitalization 2.72B 63% D 72% C

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike